Combined Targeting of EGFR, STAT3, and Bcl-XL Enhances Antitumor Effects in Squamous Cell Carcinoma of the Head and Neck

Amanda Boehm; Malabika Sen; Raja Seethala; William E Gooding; Maria Freilino; Silvia MY Wong; Shaomeng Wang; Daniel E Johnson; Jennifer R Grandis

doi:10.1124/mol.107.044636

OtherArticle

Combined Targeting of EGFR, STAT3, and Bcl-XL Enhances Antitumor Effects in Squamous Cell Carcinoma of the Head and Neck

Amanda Boehm, Malabika Sen, Raja Seethala, William E Gooding, Maria Freilino, Silvia MY Wong, Shaomeng Wang, Daniel E Johnson and Jennifer R Grandis

Molecular Pharmacology March 6, 2008, DOI: https://doi.org/10.1124/mol.107.044636

Amanda Boehm

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Malabika Sen

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Raja Seethala

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

William E Gooding

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maria Freilino

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Silvia MY Wong

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shaomeng Wang

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel E Johnson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jennifer R Grandis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
eLetters
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

In this issue

Molecular Pharmacology

Vol. 106, Issue 3

1 Sep 2024

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Combined Targeting of EGFR, STAT3, and Bcl-XL Enhances Antitumor Effects in Squamous Cell Carcinoma of the Head and Neck

Message Subject (Your Name) has forwarded a page to you from Molecular Pharmacology

Message Body (Your Name) thought you would be interested in this article in Molecular Pharmacology.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

OtherArticle

Combined Targeting of EGFR, STAT3, and Bcl-XL Enhances Antitumor Effects in Squamous Cell Carcinoma of the Head and Neck

Amanda Boehm, Malabika Sen, Raja Seethala, William E Gooding, Maria Freilino, Silvia MY Wong, Shaomeng Wang, Daniel E Johnson and Jennifer R Grandis

Molecular Pharmacology March 6, 2008, DOI: https://doi.org/10.1124/mol.107.044636

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

OtherArticle

Combined Targeting of EGFR, STAT3, and Bcl-XL Enhances Antitumor Effects in Squamous Cell Carcinoma of the Head and Neck

Amanda Boehm, Malabika Sen, Raja Seethala, William E Gooding, Maria Freilino, Silvia MY Wong, Shaomeng Wang, Daniel E Johnson and Jennifer R Grandis

Molecular Pharmacology March 6, 2008, DOI: https://doi.org/10.1124/mol.107.044636

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

Combined Targeting of EGFR, STAT3, and Bcl-XL Enhances Antitumor Effects in Squamous Cell Carcinoma of the Head and Neck

In this issue

Combined Targeting of EGFR, STAT3, and Bcl-XL Enhances Antitumor Effects in Squamous Cell Carcinoma of the Head and Neck

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals